Could a 10-Hour eating window curb appetite and improve blood sugar?

NCT ID NCT07805291

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 ยท Last updated Sep 04, 2026

Summary

Researchers at the University of Aberdeen are testing whether eating all meals within a 10-hour window, while fasting for the other 14 hours, can improve appetite control in adults with overweight or obesity. The study also compares different meal frequencies within that window, using a high-protein diet. Participants will follow two eating patterns in a crossover design, and researchers will measure appetite, blood glucose, and insulin responses on test days. The goal is to see if this eating schedule can help people feel fuller and manage their weight more effectively.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Time-restricted eating (10-hour eating window) combined with a high-protein diet and varying meal frequency
What this could lead to
If it works, this could point toward a practical eating pattern that helps people with overweight or obesity feel fuller and manage their appetite more easily.
What could go wrong
This is a small, early crossover study with only 12 participants, so results may not apply broadly. The effects on appetite and blood sugar may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Sep 2024

Finished

Aug 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (males and females), age 18-65 years * Who are healthy but overweight or obese (BMI 25+ Kg/m2) * With no history of kidney disease or bariatric surgery * Not following any specific type of medical or religious diet * Not taking any drugs that affect the rate of physical activity or metabolic circulating * Not pregnant or breastfeeding. * With a fluent understanding of the English language Exclusion Criteria: * Anyone with a BMI (in kg/m2) under 25 * Anyone under 18 years or above 65 years. * Anyone taking the statins (current), aspirin or anti-coagulants (current). * Anyone with chronic inflammatory disorders such as rheumatoid arthritis or inflammatory bowel disease * Anyone with cardiovascular disease * Anyone with diabetes * Anyone who is are planning to be pregnant, are pregnant or breastfeeding * Anyone with food allergy, self-reported food sensitivity or intolerance * Anyone with coeliac disease or gluten intolerance * Anyone with a gastrointestinal disorder, kidney disease, liver disease or gout * Anyone taking medication which may affect appetite or circadian rhythm. * Anyone with an eating disorder * Anyone suffering from unregulated thyroid disease. * Anyone using Beta Blockers which can affect the rate of physical activity. * Anyone using some anti-depressants such as mirtazapine can affect the appetite. * Anyone following a vegetarian or vegan diet * Anyone following a weight loss programme (that may affect lifestyle, physical activity \& diet) * Anyone with unsuitable veins for blood sampling * Anyone who is unable to fluently speak, read and understand English * Anyone who is unable to comply with an alcohol-free diet for 3 weeks * Anyone consumption of nutrition supplements * Anyone has the intention to donate blood within 2 months of the study. * Anyone intending to travel away from Aberdeen during the intervention phase. * Anyone who is a shift worker. * Anyone who smokes including e-cigs or vaping. * Anyone recently participated in any other research studies during the last 4 weeks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Appetite are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Intermittent Fasting Obesity obesity disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Aberdeen, The Rowett Institute, Foresterhill

    Aberdeen, Aberdeen City, AB25 2ZD, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.